Ivermectin as a Potential Therapeutic Agent for COVID-19 – case studies
Wijaya et al., Cermin Dunia Kedokteran, 47:7
Wijaya et al., Ivermectin as a Potential Therapeutic Agent for COVID-19 – case studies, Cermin Dunia Kedokteran, 47:7
Case report on 3 confirmed cases of COVID-19 with significant clinical and radiological improvement after a single dose of ivermectin.
Wijaya et al., 31 Dec 2020, peer-reviewed, 2 authors.
Abstract: LAPORAN KASUS
Ivermectin as a Potential Therapeutic Agent for
COVID-19 – case studies
Natalia Sisca Wijaya, Sidharta Salim
Mitra Kemayoran Hospital, Jakarta, Indonesia
ABSTRACT
In December 2019, an outbreak of a novel coronavirus (SARS-CoV-2) started in Wuhan, China, and has since become a global threat to human
health. To date, the worldwide response to the COVID-19 outbreak has been limited mainly to monitoring/containment. Several types of drug,
as well as vaccination, are still under investigation and clinical trials worldwide. Recently, a study demonstrated ~5000-fold reduction in SARSCoV-2 virus at 48h in cell culture after a single treatment of ivermectin. A clinical study at the University of Utah found that the administration
of ivermectin during COVID-19 illness in hospitalized patients is associated with lower mortality and hospital length of stay. We report three
confirmed cases of COVID-19 infection with significant improvement clinically and radiologically, with following treatment single dose of
ivermectin
Keywords: Ivermectin, SARS-CoV-2, COVID-19
ABSTRAK
Pada Desember 2019, wabah yang disebabkan oleh varian baru coronavirus (SARS-CoV-2) dimulai di Wuhan, China, dan saat ini telah menjadi
ancaman global bagi kesehatan manusia. Hingga saat ini, respons dunia terhadap wabah COVID-19 masih terbatas pada pemantauan dan
isolasi. Di seluruh dunia, beberapa jenis obat dan juga vaksinasi masih menjalani tahap investigasi dan uji klinis. Baru-baru ini, sebuah studi
mendemonstrasikan bahwa satu dosis ivermectin mampu mengurangi ~5000-kali kadar SARS-CoV-2 virus dalam 48 jam pada kultur sel.
Sebuah uji klinis di Universitas di Utah juga membuktikan bahwa ivermectin terbukti menurunkan angka mortalitas dan juga lama perawatan
pasien COVID-19 rawat inap. Kami melaporkan tiga pasien dengan konfirmasi positif COVID-19 yang menunjukkan kemajuan signifikan klinis
dan radiologis setelah pengobatan dengan satu dosis ivermectin. Natalia Sisca Wijaya, Sidharta Salim. Ivermectin sebagai Agen Terapeutik
Potensial untuk COVID-19 – studi kasus
Kata kunci: Ivermectin, SARS-CoV-2, COVID-19
Late treatment
is less effective
Please send us corrections, updates, or comments. Vaccines and
treatments are complementary. All practical, effective, and safe means should
be used based on risk/benefit analysis. No treatment, vaccine, or intervention
is 100% available and effective for all current and future variants. We do not
provide medical advice. Before taking any medication, consult a qualified
physician who can provide personalized advice and details of risks and
benefits based on your medical history and situation.
FLCCC and
WCH
provide treatment protocols.
Submit